Xilio Therapeutics, Inc.

NasdaqGS:XLO Stock Report

Market Cap: US$37.9m

Xilio Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:XLO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Apr 24BuyUS$368,790Gilead Sciences, Inc.Company485,250US$0.76
08 Feb 24SellUS$640Atlas Venture L.P.Company1,000US$0.64
12 Jan 24SellUS$3,600Atlas Venture L.P.Company4,235US$0.87

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of XLO?
Owner TypeNumber of SharesOwnership Percentage
Private Companies13,9750.0405%
Individual Insiders206,6350.6%
Hedge Funds3,003,2598.71%
Public Companies7,345,47321.3%
VC/PE Firms7,467,19321.7%
General Public7,589,52122%
Institutions8,841,81325.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 25.7%.


Top Shareholders

Top 25 shareholders own 77.76% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
21.3%
Gilead Sciences, Inc.
7,345,473US$8.1m0%no data
8.71%
Rock Springs Capital Management LP
3,003,259US$3.3m108%0.1%
8.14%
Bain Capital Life Sciences Investors, LLC
2,805,413US$3.1m0%0.32%
7.99%
Atlas Venture L.P.
2,754,109US$3.0m-0.19%0.34%
5.53%
Impresa Management LLC
1,907,671US$2.1m0%0.91%
4.68%
SV Health Investors, LLC
1,613,632US$1.8m0%100.0%
4.3%
M Ventures
1,483,414US$1.6m0%7.47%
4.28%
Takeda Ventures, Inc.
1,475,121US$1.6m0%36.14%
4.18%
RiverVest Venture Management LLC
1,441,444US$1.6m0%20.25%
2.62%
The Vanguard Group, Inc.
902,531US$992.8k1.37%no data
1.31%
Artal Group S.A.
450,000US$495.0k0%0.02%
0.72%
Columbia Investment Management Company
249,635US$274.6k0%0.56%
0.63%
Fidelity International Ltd
218,705US$240.6k0%no data
0.61%
Renaissance Technologies LLC
209,700US$230.7k913%no data
0.58%
Rene Russo
200,633US$220.7k0%no data
0.45%
Bridgeway Capital Management, LLC
155,481US$171.0k40.7%no data
0.37%
Morgan Stanley, Investment Banking and Brokerage Investments
127,265US$140.0k385%no data
0.34%
Laurion Capital Management LP
116,847US$128.5k-16.1%no data
0.25%
Geode Capital Management, LLC
84,826US$93.3k0%no data
0.24%
ArrowMark Colorado Holdings, LLC
83,373US$91.7k0%no data
0.15%
Citadel Advisors LLC
51,419US$56.6k0%no data
0.14%
BlackRock, Inc.
46,862US$51.5k-1.1%no data
0.088%
Millennium Management LLC
30,351US$33.4k0%no data
0.077%
Dimensional Fund Advisors LP
26,449US$29.1k0%no data
0.052%
Northern Trust Global Investments
17,798US$19.6k0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.